Meet the team
Who We Are
New Equilibrium brings together interdisciplinary experts with the shared goal of drugging intrinsically disordered proteins.
Internal Team
Virginia Burger, Ph.D.
Co–founder and CEO
Soumya Ray, Ph.D.
Interim CTO
Peter Tompa, Ph.D.
Co–founder and Chair of SAB
Charles DeLisle, Ph.D.
Principal Scientist, Biophysics
Hsiao-Yun Chen, Ph.D.
Principal Scientist, Biochemistry & Cell Biology
Lars Bratholm, Ph.D.
Principal Scientist, Machine Learning
Tao Jiang, Ph.D.
Principal Scientist, Computational Chemistry
Acadia Connor, B.A.
Research Associate II and Manager, MD Hardware
Bentley Wingert, Ph.D.
Scientist I, Computational Chemistry
Hang Cao, B.F.A.
Communications Manager and DEI Coordinator
Austin Alexander, B.S.
Operations ManagerScientific Advisory Board
VK Gadi, M.D. PH.D.
Professor and Director, Medical Oncology, U of Illinois at Chicago
Lila M. Gierasch, Ph.D.
Professor, Chemistry & Biochemistry and Molecular Biology, UMass Amherst
Emir Roach, M.D.
Principal, Biopharma, Boston Consulting Group
Sally Wang Liang, J.D./M.P.H.
VP of Business Development, Head of Global Business Unit, PepLib
Olexandr Isayev, Ph.D.
Professor, Department of Chemistry, Carnegie Mellon University
Keith Dunker, Ph.D.
Professor Emeritus of Biochemistry and Molecular Biology, Indiana University